FrieslandCampina has struck a partnership with US-based Glycosyn.
ADVERTISEMENT
Dutch dairy giant FrieslandCampina has announced a new partnership with Glycosyn, a US-based biotechnology company that produces nutritional products from milk. Glycosyn will work with Friesland’s ingredients division, using its technology to develop new products and ingredients for use in Friesland’s infant formula brand Domo.
Tine Snels, executive director of FrieslandCampina’s ingredients division, said the partnership will allow the group develop the next generation of infant nutrition products.
“We are doing this to meet the growing global demand for high-quality ingredients. Our cooperation is a perfect example of co-creation. The first quantities for trials will be available in the current year,” added Snels.
ADVERTISEMENT
Human milk oligosaccharides (HMOs) are specialised carbohydrates which are naturally prevalent in mother’s milk. Glycosyn has developed a technology to produce oligosaccharides from lactose and Friesland hopes to use this technology as a new ingredient in its infant formula range.
Register for free to read this story and our free stories.
This content is available to digital subscribers and loyalty code users only. Sign in to your account, use the code or subscribe to get unlimited access.
The reader loyalty code gives you full access to the site from when you enter it until the following Wednesday at 9pm. Find your unique code on the back page of Irish Country Living every week.
CODE ACCEPTED
You have full access to the site until next Wednesday at 9pm.
CODE NOT VALID
Please try again or contact support.
Dutch dairy giant FrieslandCampina has announced a new partnership with Glycosyn, a US-based biotechnology company that produces nutritional products from milk. Glycosyn will work with Friesland’s ingredients division, using its technology to develop new products and ingredients for use in Friesland’s infant formula brand Domo.
Tine Snels, executive director of FrieslandCampina’s ingredients division, said the partnership will allow the group develop the next generation of infant nutrition products.
“We are doing this to meet the growing global demand for high-quality ingredients. Our cooperation is a perfect example of co-creation. The first quantities for trials will be available in the current year,” added Snels.
Human milk oligosaccharides (HMOs) are specialised carbohydrates which are naturally prevalent in mother’s milk. Glycosyn has developed a technology to produce oligosaccharides from lactose and Friesland hopes to use this technology as a new ingredient in its infant formula range.
If you would like to speak to a member of our team, please call us on 01-4199525.
Link sent to your email address
We have sent an email to your address. Please click on the link in this email to reset your password. If you can't find it in your inbox, please check your spam folder. If you can't find the email, please call us on 01-4199525.
ENTER YOUR LOYALTY CODE:
The reader loyalty code gives you full access to the site from when you enter it until the following Wednesday at 9pm. Find your unique code on the back page of Irish Country Living every week.
SHARING OPTIONS